The previous page is sending you to http://www.marketwire.com/press-release/eyegate-pharma-enrolls-last-patient-pivotal-phase-iii-anterior-uveitis-study-egp-437-1738716.htm.

 If you do not want to visit that page, you can return to the previous page.